Opinion · 25 Jun 2026
Conference abstractPublished 17 Sep 2012
Never-in mitosis A-related protein kinase, Nek1, and renal cell carcinoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Renal cell carcinoma (RCC) is a heterogeneous disease with poor prognosis because its high resistance to systematic chemotherapy. Overexpression of multiple drug resistance (MDR) has been implicated as one of the mechanisms for RCC�s chemoresistance. Through examination of the expression level of a panel of proteins involved in the DNA damage repair pathway, Never-in mitosis A-related protein kinase 1 (Nek1) was found highly expressed in RCC tumor and cultured RCC cells compared to normal renal tubular epithelial (RTE) cells. Previously, we have shown that association between Nek1 and the voltage dependent anion channel (VDAC1) is tightly regulated and crucial for cell survival in response to genotoxic treatment. Here, we found that elevated protein level of Nek1 leads to prolonged Nek1/VDAC1 association under genotoxic insult. As a result, persistent VDAC1 phosphorylation was found and resulting in VDAC1 channel closure and prevent cells from apoptosis. Thus, increased Nek1 expression in RCC cells keeps the VDAC1 channel closed and prevents apoptosis under genotoxic insult, and may serve an important mechanism in the chemo-resistant phenotype of RCC. Support the hypothesis, down-regulation of Nek1 expression in RCC cells by using the adenovirus mediated shRNA significantly increases the sensitivity of RCC to DNA damaging treatment when compared to cells treated with control virus which silences expression of firefly luciferase. In this study, we show an alterative mechanism to account for RCC�s chemoresistance, thereby providing an additional prognostic marker as well as a potential therapeutic target for drug development in the treatment of RCC.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Translational Medicine.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalTranslational Medicine
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Yumay Chen”
